CHRISTOPHER CAUSEY - 02 Nov 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 02 Nov 2022
Net transactions value: -$559,299
Form type: 4
Filing time: 03 Nov 2022, 16:30:30 UTC
Previous filing: 25 Aug 2022
Next filing: 03 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$438,575	+2,500	+88%	$175.43	5,335	02 Nov 2022	Direct	F1
transaction	UTHR	Common Stock	Sale	$600,000	-2,500	-47%	$240.00	2,835	02 Nov 2022	Direct	F1
transaction	UTHR	Common Stock	Options Exercise	$438,575	+2,500	+88%	$175.43	5,335	02 Nov 2022	Direct	F1
transaction	UTHR	Common Stock	Sale	$625,024	-2,500	-47%	$250.01^*	2,835	02 Nov 2022	Direct	F1, F2
transaction	UTHR	Common Stock	Options Exercise	$438,575	+2,500	+88%	$175.43	5,335	03 Nov 2022	Direct	F1
transaction	UTHR	Common Stock	Sale	$650,000	-2,500	-47%	$260.00	2,835	03 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Stock Options	Options Exercise	$0	-2,500	-22%	$0.000000	9,000	02 Nov 2022	Common Stock	2,500	$175.43	Direct	F1
transaction	UTHR	Stock Options	Options Exercise	$0	-2,500	-28%	$0.000000	6,500	02 Nov 2022	Common Stock	2,500	$175.43	Direct	F1
transaction	UTHR	Stock Options	Options Exercise	$0	-2,500	-38%	$0.000000	4,000	03 Nov 2022	Common Stock	2,500	$175.43	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2	This transaction was executed in multiple trades at prices ranging from $250.00 to $250.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.